LIGAND PHARMACEUTICALS INCORPORATED Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIGAND PHARMACEUTICALS INCORPORATED stock issued during period, value, new issues for the quarter ending 2024-09-30 was $34.03M.
- LIGAND PHARMACEUTICALS INCORPORATED stock issued during period, value, new issues for fiscal 2024 was $37.14M.
- LIGAND PHARMACEUTICALS INCORPORATED stock issued during period, value, new issues for fiscal 2013 was $5.31M, a 0.00% change from fiscal 2012.
- LIGAND PHARMACEUTICALS INCORPORATED stock issued during period, value, new issues for fiscal 2012 was $5.31M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $37.14M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $34.03M 10-Q · filed 2025-11-07 | |
| 2013-12-31 | $5.31M 10-K · filed 2014-12-01 | |
| 2012-12-31 | $5.31M 10-K · filed 2015-02-23 |